LONDON (Alliance News) - ReNeuron Group PLC Wednesday said Non-Executive Director John Berriman has stepped up to be chairman after Bryan Morton, who has held the position since 2011, stepped down from the board.
The company's board will also lose Non-Executive Director Mark Docherty, who will step down at its Annual General Meeting in September, and Chief Scientific Officer John Sinden, who will step down at the same time. Sinden will remain CSO, focusing on third party research collaborations and other externally facing activities.
Randolph Corteling will take on the day-to-day management of the company's in-house research function, having been promoted to the role of head of research with immediate effect, from his current role of head of cell biology.
ReNeuron also said it is finalising the appointment of two further new positions in the senior management team, that of chief medical officer and head of regulatory affairs.
Sharon Grimster has been appointed as the company's general manager, Wales.
"The changes announced today are part of an ongoing, phased restructuring of the executive and non-executive teams as the company evolves and transitions into its next stage of development. In this regard, the board of the company has decided to further strengthen the executive management of the business, with a commensurate reduction in size of the non-executive board," it said.
ReNeuron shares were down 3.5% at 3.50 pence Wednesday morning.
By Steve McGrath; stevemcgrath@alliancenews.com; @stevemcgrath1
Copyright 2015 Alliance News Limited. All Rights Reserved.
Reneuron (RENE)